PRO 140 requires one dose a week, rather than daily pills Treatment has shown hardly any side-effects in clinical trials, while current HIV therapies may cause mild to severe side-effects CytoDyn’s treatment is simple for patients to administer with hardly any toxicity Significant advantages of PRO 140, CytoDyn Inc.’s (OTCQB: CYDY) viral-entry inhibitor, over drugs […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.